Biogen’s Alzheimer’s disease treatment reduced amyloid plaque in patients’ brains in an early-stage trial, in what is being hailed as “game-changing.” But although promising, onlookers remain cautious of overhyping a drug candidate that had provided weak results just last year. The Phase 1b data, published today in Nature, showed aducanumab, an amyloid-targeting monoclonal antibody, lowered…
Cancer Outpaces Heart Disease as Europe’s Leading Killer
Although cardiovascular disease is the leading cause of death worldwide, cancer is moving into a lead role among men in a dozen European countries. While cancer deaths are increasing in Europe, deaths from cardiovascular disease are decreasing, likely due to improvements in prevention and treatment, according to an analysis published in the European Heart Journal.…
Large Study Finds 15 Genetic Sites Linked to Depression
Depression is caused by a combination of factors, biological predisposition triggered by environment, which makes the disorder so complex. Now, in an attempt to understand the biological underpinnings of depression, a recent study revealed 15 locations in the human genome associated with the development of major depressive disorder. The study, published in Nature Genetics, spanned…